In vitro studies of graphene oxide reinforced hydroxyapatite nanobiocomposite on human erythrocytes

We report the interaction of graphene oxide reinforced hydroxyapatite (GO-HAp) nanocomposites with human erythrocytes. The hemocompatibility of GO-HAp found to be superior as compared to the pristine graphene oxide. It is found that the HAp nanoparticles on GO decrease the disruption of erythrocytes by minimizing the exposure of oxygen groups to phosphatidylcholine surface of erythrocyte membrane and it enhances hemocompatibility. Further, it is also found that the graphene oxide reinforced HAp nanobiocomposite enhances the metabolic activity of osteoblasts-like cells by promoting cell proliferation.